Santos, J. M., & Mauro Oscar Grossmann, M. O. G. (2023). Systematic review: cost-benefit of Dapagliflozin versusSacubitril/Valsartan in HFrEF. Interamerican Journal of Health Sciences, 3, 149. https://doi.org/10.59471/ijhsc2023149